# Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas

> **NCT00042991** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 69 (actual)

## Conditions studied

- Untreated Childhood Anaplastic Astrocytoma
- Untreated Childhood Anaplastic Oligodendroglioma
- Untreated Childhood Brain Stem Glioma
- Untreated Childhood Giant Cell Glioblastoma
- Untreated Childhood Glioblastoma
- Untreated Childhood Gliomatosis Cerebri
- Untreated Childhood Gliosarcoma
- Untreated Childhood Oligodendroglioma

## Interventions

- **DRUG:** gefitinib
- **RADIATION:** radiation therapy
- **OTHER:** pharmacological study
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00042991
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2010-02
- **Final completion:** 2010-03
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2014-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00042991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00042991, "Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00042991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*